FDA Grants Tentative Approval for Aurobindo's Antiretroviral Drug Abacavir
May 25, 2006
Indian drug manufacturer Aurobindo Pharma has received tentative approval from FDA to produce 300 mg tablets of abacavir sulfate, which is used in combination with other antiretroviral drugs to treat HIV-1 infection, the company announced on Tuesday, the Hindu Business Line reports. Abacavir is the generic version of GlaxoSmithKline's Ziagen. The product will be eligible for consideration under the President's Emergency Plan for AIDS Relief, according to a press release from the company (Hindu Business Line, 5/24).
Health Sector in Northern Cote d'Ivoire Destroyed by Civil War; HIV/AIDS Prevention, Treatment Efforts Undermined
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.